Tibet Weixinkang Medicine Co Ltd (603676) — Cash Flow Quality Index
Tibet Weixinkang Medicine Co Ltd (603676) has a Cash Flow Quality Index of 0.38x as of September 2025. Operating cash flow of CN¥13.68 Million is below net income of CN¥36.39 Million, suggesting accrual-heavy earnings not yet converted to cash. Explore Tibet Weixinkang Medicine Co Ltd cash flow to debt ratio to assess how comfortably operating cash covers total debt obligations.
Cash Flow Quality Index
Operating Cash Flow
Net Income
Data as of
Tibet Weixinkang Medicine Co Ltd Cash Flow Quality Index (2013–2025)
Historical Cash Flow Quality Index for Tibet Weixinkang Medicine Co Ltd across 13 annual periods. Values consistently above 1.0x indicate high-quality earnings. For the full cash flow conversion analysis, see 603676 cash flow metrics.
Annual Cash Flow Quality Index for Tibet Weixinkang Medicine Co Ltd (2013–2025)
Year-by-year earnings quality comparison for Tibet Weixinkang Medicine Co Ltd.
| Year | Quality Index | Operating CF (CNY) | Net Income | YoY Change |
|---|---|---|---|---|
| 2025 | 0.80x | CN¥185.53 Million | CN¥232.85 Million | ▼ -47.4% |
| 2024 | 1.51x | CN¥372.78 Million | CN¥246.17 Million | ▲ +26.3% |
| 2023 | 1.20x | CN¥256.67 Million | CN¥214.02 Million | ▼ -13.8% |
| 2022 | 1.39x | CN¥246.15 Million | CN¥176.96 Million | ▼ -21.8% |
| 2021 | 1.78x | CN¥170.69 Million | CN¥95.91 Million | ▼ -22.2% |
| 2020 | 2.29x | CN¥133.70 Million | CN¥58.42 Million | ▲ +19.8% |
| 2019 | 1.91x | CN¥106.34 Million | CN¥55.68 Million | ▲ +68.6% |
| 2018 | 1.13x | CN¥83.17 Million | CN¥73.44 Million | ▲ +81.8% |
| 2017 | 0.62x | CN¥63.30 Million | CN¥101.59 Million | ▼ -31.0% |
| 2016 | 0.90x | CN¥103.79 Million | CN¥114.92 Million | ▼ -10.8% |
| 2015 | 1.01x | CN¥114.47 Million | CN¥113.03 Million | ▼ -0.7% |
| 2014 | 1.02x | CN¥118.47 Million | CN¥116.20 Million | ▲ +1.0% |
| 2013 | 1.01x | CN¥88.59 Million | CN¥87.74 Million | — |